DD
DDT
DILLARD'S, INC.
$26.13
-0.10%
$408.4M
No data for this timeframe.
Vol
Market Cap$408.4M
Cap SizeSmall Cap
Reddit Sentiment78° Bullish
SEC Reports2
Recent Activity
Apr 6, 2026
SEC
Dillard's, Inc. is proposing a merger with its family holding company, W.D. Company, Inc., to simplify corporate structu
DEFM14A — Impact 5/10
Mar 27, 2026
SEC
Dillard's, Inc. is proposing a merger with W.D. Company, Inc. (WDC), a family holding company that owns a controlling st
PREM14A — Impact 4/10
Latest Reports
NEUTRAL
DEFM14A
5/10
Dillard's, Inc. is proposing a merger with its family holding company, W.D. Company, Inc., to simplify corporate structu
Apr 6, 2026
NEUTRAL
PREM14A
4/10
Dillard's, Inc. is proposing a merger with W.D. Company, Inc. (WDC), a family holding company that owns a controlling st
Mar 27, 2026
Reddit Sentiment
78°
Bullish
Bearish
Neutral
Bullish
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 4.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
No analyst rating data available yet. Consensus ratings and individual firm actions are collected periodically from financial data providers.
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
78°
Bullish
Bearish
Neutral
Bullish
5 mentions
5 bullish
0 bearish
5 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 14, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 14, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 23, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 23, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 14, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.